133 DYSREGULATION OF FIBROBLAST GROWTH FACTOR NETWORK IN EARLY HEPATOCELLULAR CARCINOMA

Victoria Tovar; Hömig-Hölzel Cornelia; Yujin Hoshida; S. Toffanin; A. Villanueva; Daniela Sia; Judit Peix; Anja Lachenmayer; Clara Alsinet; M Solé; M. Schwartz; Vincenzo Mazzaferro; Jordi Bruix; Josep M. Llovet

doi:10.1016/s0168-8278(11)60135-9

Related publications

Article2021

Hepatocellular carcinoma

Josep M. Llovet, Robin Kate Kelley, Augusto Villanueva, Amit G. Singal, Eli Pikarsky, Sasan Roayaie, Riccardo Lencioni, Kazuhiko Koike, Jessica Zucman‐Rossi, Richard S. Finn

Nature Reviews Disease Primers

Article2016

Hepatocellular carcinoma

Josep M. Llovet, Jessica Zucman‐Rossi, Eli Pikarsky, Bruno Sangro, M. Schwartz, Morris Sherman, Gregory J. Gores

Nature Reviews Disease Primers

Chapter in a book2006

Hepatocellular Carcinoma

Jordi Bruix, C. Bru, Josep M. Llovet

Article2000

Surgical resection versus transplantation for early hepatocellular carcinoma: clues for the best strategy

Josep M. Llovet, Jordi Bruix, Gregory J. Gores

Hepatology

Article2004

Treatment of hepatocellular carcinoma

Josep M. Llovet

Current Treatment Options in Gastroenterology

133 DYSREGULATION OF FIBROBLAST GROWTH FACTOR NETWORK IN EARLY HEPATOCELLULAR CARCINOMA

Abstract

Discussion(0)

Related publications

Hepatocellular carcinoma

Hepatocellular carcinoma

Hepatocellular Carcinoma

Surgical resection versus transplantation for early hepatocellular carcinoma: clues for the best strategy

Treatment of hepatocellular carcinoma